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Glutamatergic VP neurons exhibit distinct neurochemical and membrane properties.
We first determined whether glutamatergic VP neurons overlapped with canonical VP subtypes. We injected DIO-mCherry to the VP of VGluT2-IRES-Cre mice to visualize glutamatergic neurons ( Figure 1A ). The VP is predominantly GABAergic, with cholinergic and PV-positive neurons (22, 32, 33). We immunostained against PV or choline acetyltransferase (ChAT), and quantified overlap with mCherry-expressing neurons. PV was co-expressed in 17.5 ± 2.06% of VGluT2-positive neurons, and the extent of overlap varied as a function of anterior to posterior gradient, with highest co-localization occurring in the anterior VP (anterior 22.6 ± 4.6%, medial 19.7 ±2.5%, posterior 9.2 ± 2.4%; Figure 1B ). ChAT co-labelled with 4.3 ± 1.8% of VGluT2-positive neurons ( Figure 1C ).
Most VP neurons are GABAergic (12, 22) . To determine extent of overlap between VGluT2-positive and GABAergic neurons, we performed fluorescent in situ hybridization to detect Slc17A6 (VGluT2) and Slc31A1 (VGAT) mRNA and quantified overlap of fluorescent signals. Slc31A1 mRNA was observed in very few (1.98 ± 0.66 %) Slc17A6-expressing neurons ( Figure 1D ), suggesting sparse neurons capable of both glutamate and GABA release ( Figure 1D ).
Having established that glutamatergic VP neurons exhibit low co-expression with markers of canonical VP subtypes, we asked whether these neurons also exhibited distinct membrane properties. We injected DIO-eYFP to the VP of mice expressing Cre-in VGluT2-VGAT-ChAT-or PV-positive neurons and performed patch clamp recordings of genetically-identified subtypes (Figure 2A-D) . The majority (60%) of GABA neurons could be classified according to published criteria [24, 25, 35] . These GABA neurons were classified Type I based on depolarized membrane potentials (-51.23 ± 2.77 mV) and spontaneous firing (4.78 ± 0.42 Hz), while Type II neurons exhibited membrane potentials below -60 mV (-64.46 ± 1.52 mV) and low spontaneous activity (0.47 ± 0.16 Hz). Type I and Type II neurons differed in capacitance (Type I = 18.6 ± 1.7 pF, Type II = 13.4 ± 2.6 pF). Consistent with previous studies, ChAT-positive VP neurons exhibited burst firing with average firing rate of 2.04 ± 1.0 Hz, large capacitance (32.41 ± 2.15 pF) and resting potential of -58.05 ± 1.79 mV. PV-positive neurons exhibited a membrane capacitance of 17.6 ± 2.3 pF, depolarized membrane potential (-51.33 ± 1.62 mV) and high spontaneous activity (9.77 ± 0.89 Hz). VGluT2-positive VP neurons exhibited small capacitance (14.1 ± 1.3 pF) and low firing rates (0.86 ± 0.75 Hz), similar to Type II neurons. However, the resting membrane potential of VGluT2-positive VP neurons was hyperpolarized (-78.48 ± 2.8 mV), and these neurons were significantly less excitability than all other cell types ( Figure 2C ).
Glutamatergic VP neurons receive input from striatum and amygdala and innervate the LHb, RMTg and VTA.
Whole-brain scanning was used to detect monosynaptic inputs to glutamatergic VP neurons, labeled with pseudo-rabies virus conjugated to green fluorescent protein (GFP; Figure 3A ). The number of GFP-positive cells was quantified in each upstream brain region (according to the atlas of Paxinos and Franklin; 36), and the number of GFP-positive cells in each brain area was expressed as a proportion of the total GFP-positive cells quantified M A N U S C R I P T
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across all brain regions ( Figure 3B ). The VP is the primary output of the NAc [37] . As predicted from earlier tracing studies [38, 39] , the majority of GFP-positive cells were concentrated in the NAc shell (20.5 ± 6.2%) and core (9.7 ± 3.7%), and medial wall of the dorsomedial striatum (9.1 ± 2.0%). A significant proportion of GFP-positive cells were also observed in the central (CeA; 5.8 ± 1.3%) and medial (9.1 ± 4.3%) sub-regions of the amygdala. Cortical and midbrain regions were also represented, consistent with the canonical, established inputs to the VP ( Figure 3B VTA GABA = 0.67 ± 0.22). There was no significant difference in EPSC or IPSC PPR in any region ( Figure 4F ). We confirmed that EPSCs were blocked by the AMPA receptor NBQX while outward IPSCs were blocked by PTX ( Figure   4G ).
Activation of glutamatergic neurons modulates firing activity of LHb, RMTg and VTA neurons in vivo.
Our patch clamp physiology results indicate that terminal field activation of glutamatergic VP neurons in the LHb, VTA and RMTg evokes predominantly EPSCs. However, there is extensive connectivity between these downstream regions; for example, the LHb sends excitatory afferents to the RMTg, which in turn inhibits DA neurons in the VTA (34, 35). Due to this reciprocal connectivity, potential network effects of glutamatergic VP neuron activation on firing rates of these downstream neurons that would not be evident in a slice preparation. To determine the effect of glutamatergic VP neuron activation on firing rates, we performed in vivo recording of the LHb, RMTg and VTA in anesthetized mice and determined the response to activation of glutamatergic VP neurons ( Figure 5A ,B).
We identified 51 LHb units (4.00 ± 1.60 Hz), 28 of which were significantly modulated by stimulation of glutamatergic VP neurons; of these 28 significantly light-modulated units, all 28 increased their firing rate ( Figure   5C ). Similarly, we recorded 53 RMTg units (3.79 ± 0.76 Hz), 26 of which were significantly light-modulated ( Figure   5D ); increased firing rate was observed in nearly all (24/26) units, while decreased firing rate was observed in the M A N U S C R I P T
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were positively light-modulated. Of the negatively-modulated units, baseline firing rate was 1.43 ± 0.34 Hz, which decreased by 22.45% in response to light. Of the positively-modulated units, baseline firing was 3.76 ± 1.05 Hz and increased by 36.03% in response to light ( Figure 5E ). There was no difference between animals in terms of baseline (VTA DA: F 2 = 1.897, p = 0.244, VTA GABA: F 2 = 0.799, p = 0.500, LHb: F2 = 1.58, p = 0.225, RMTg: F2 = 0.826, p = 0.450) or light-evoked change in firing (VTA DA: F 2 = 1.500, p = 0.296, VTA GABA: F 2 = 0.572, p = 0.593, LHb: F 2 = 0.540, p = 0.589, RMTg: F2 = 1.533, p = 0.237). We compared the variability in latency to peak change in firing rate for each unit (Supplemental Figure 1) . There was no significant difference in the latency to peak change in firing rate or in variance to peak firing rate between brain areas, nor was there a significant relationship between latency to peak change and magnitude of peak change in firing rate. In the temporal cortex, a control region that does not receive input from the VP, there was no significant modulation of LFP response or of spiking activity of any of the 7 identified units (Supplemental Figure 2) .
Glutamatergic VP neurons constrain reward seeking and contribute to aversion learning
We non-selectively stimulated VP neurons in an RTPP task ( Figure 6A -C). Mice expressing ChR2 but not eYFP exhibited a robust preference for the stimulation-paired side (ChR2: baseline: 51.1 ± 1.4%, stim: 77.1 ± 4.9%; eYFP: baseline: 49.7 ± 1.7, stim: 47.0 ± 5.1%; Figure 6D ). Stimulation of glutamatergic VP neurons at 20 Hz induced place aversion (baseline: 49.9 ± 2.8%, stim: 23.1 ± 6.3, Figure 6E -F), while cre-negative mice that did not express the optogenetic effector showed no preference or avoidance of the stimulation-paired side (baseline: 53.1 ± 2.5%, stim: 52.8 ± 3.1%, Figure 6E -F). 10 Hz (Change from baseline: -22.55 ± 3.19%, t = 7.058, p = 0.006) but not 1 Hz stimulation (Change from baseline: 7.80 ± 7.18%, t = 1.087, p = 0.357) induced real time place avoidance.
To interrogate the role of glutamatergic VP neurons in reward seeking and motivation, we trained mice on an operant reward task before selective ablation of glutamatergic VP neurons with AAV2-flex-taCasp3-TEVp. Mice first learned a fixed ratio (FR) task where lever presses were rewarded with a sucrose pellet ( Figure 7A ). There was no effect of geneotype on the initial acquisition of the fixed ratio (FR) responding task ( Figure 7B ). There was no effect of taCasp3 lesion on number lever presses made in the FR task (Cre-= pre: 197.83 ± 9.5, post: 264.13 ± 12.4 presses/session, Cre+ = pre: 183.78 ± 10.65, post: 214.53 ± 10.8 presses/session; Figure 7C ); however, there was a significant increase in rate of responding in taCasp3-lesioned mice (Cre-= pre: 36.09 ± 1.9, post: 39.36 ± 2.54 min/session, Cre+ = pre: 36.12 ± 2.6, post: 22.04 ± 2.31 min/session; Figure 7D ). Following taCasp3 lesion, the number of lever presses in the PR task increased (Cre-= pre: 372.11 ± 28.14, post: 443.39 ± 32.9 presses/session, Cre+ = pre: 496.24 ± 48.87, post: 1656.62 ± 444.88 presses/session), as did the breakpoint (Cre-= pre: 14.47 ± 0.38, post: 15.0 ± 0.41, Cre+ = pre: 15.2 ± 0.3, post: 19.0 ± 0.42, F session x genotype = 5.09, p = 0.001; Figure 7E ) and time of active lever pressing during the session (F geneotype = 245.011, p < 0.001; F session x geneotype = 4.727, p = 0.026;).
In a sucrose aversion task, mice with taCasp3 lesions or controls were allowed free access to 5 % sucrose solution. After sucrose intake stabilized over 4 days, mice were injected with LiCl and testing was conducted M A N U S C R I P T
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identically the following day ( Figure 7F ). Baseline drinking time was higher in taCasp-lesioned mice relative to controls, consistent with their increased responding and higher breakpoint in the operant task. As previously reported (36), LiCl injection significantly reduced sucrose consumption in control mice (50.3 ± 11.1% decrease from baseline). However, mice with taCasp lesions of glutamatergic VP neurons showed no change in sucrose consumption following LiCl injection (31.4 ± 9.4% non-significant change; Figure 7G ). There were no differences in spontaneous locomotor activity in an open field task between unlesioned (82.74 ± 20.83 m) and lesioned mice (77.7 ± 17.53; Figure 7I ).
Discussion
The VP is a critical region for the expression of motivated behavior and for processing rewarding and aversive stimuli. Dissecting the heterogeneity of the VP is essential for understanding how the VP contributes to coordinating behavioral responses to rewarding and aversive stimuli and is necessary for understanding reward seeking in adaptive and pathological states. Glutamatergic VP neurons overlap minimally with GABAergic or cholinergic cell markers (Figure 1 ). Analagous to the external globus pallidus, the VP has been reported to contain PV-positive projection neurons (37), some of which are capable of glutamate release (27). We found that PVpositive neurons accounted for only a small proportion (17.5 %) of glutamatergic neurons, the majority of glutamatergic VP neurons did not co-localize with PV. Likewise, only a small proportion of PV-positive VP neurons express VGluT2 (19.5% (27)). Electrophysiological measurement of membrane properties further indicate that glutamatergic neurons are a distinct subclass: VGluT2-positive neurons exhibited a hyperpolarized membrane potential relative to previously categorized GABAergic or cholinergic neurons ( Figure 2 ). While our immunohistochemistry results indicated small overlap between glutamatergic and PV-positive neurons, our recording from identified PV-positive neurons consistently found slightly depolarized membrane potentials and high rates of spontaneous firing (Figure 2 ), unlike the hyperpolarized potential and lack of spontaneous firing observed in the identified VGluT2-positive population. One possibility is that our recordings of identified VGluT2-positive neurons did not sample from the small sub-population that co-express PV. Future studies will elucidate whether there are meaningful functional properties of the subpopulation of VP neurons that co-express PV and VGluT2. These results indicate that glutamatergic neurons constitute a subclass distinct from classically-described VP cell types.
Given their unique neurochemical and electrophysiological identity, we next asked whether glutamatergic neurons exhibited unique afferent and efferent connections relative to classical VP subtypes. Consistent with early tracing studies of inputs to the VP (5, 37, 38), our pseudo rabies tracing revealed monosynaptic inputs to glutamatergic VP neurons arising predominantly from the NAc, but also from cortical and amygdala regions ( Figure   3 , Table 1 ). Our study did not determine the neurochemical identity of these upstream projections, although functional in vivo electrophysiology studies have determined that inputs from the NAc are GABAergic, projections According to models of input-output relationships of the VTA (45, 49), the putative VTA DA neurons we recorded project to the NAc; a decrease in DA firing and consequent decrease in DA release in the NAc would reduce likelihood of repeating actions that lead to that outcome. Based on these network effects, we hypothesized that activation of glutamatergic VP neurons would result in behavioral avoidance response to stimulation. Strikingly, while non-specific stimulation of the VP produced robust place preference, consistent with the reinforcing properties of VP stimulation in ICSS studies (50, 51), selective stimulation of glutamatergic VP neurons induced a real-time avoidance of stimulation ( Figure 6 ). This indicates that glutamatergic VP neurons are situated to play a unique role in reward-related behavior. Given that VP-lesions decrease reward motivation (15, 16 , 21), we asked whether selective lesions of glutamatergic VP neurons would have the opposing effect. Virally-mediated caspase ablation of glutamatergic VP neurons increased the rate of responding for sucrose and enhanced motivation for sucrose in a PR task ( Figure 7 ). Finally, we asked whether glutamatergic VP neurons are necessary for adaptively constraining reward seeking by testing the avoidance response to sucrose paired with LiCl. We found that ablation of glutamatergic VP neurons rendered mice insensitive to sucrose devaluation with LiCl, further supporting the idea that glutamatergic VP neurons adaptively constrain reward seeking. In addition to this role in constraining reward seeking, future work will determine whether activity of glutamatergic VP neurons alters reward thresholds or contributes to behavioral responses to aversive stimuli beyond the context of reward seeking.
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Substance use and mood disorders are characterized by maladaptive reward seeking. The VP is a central node in the reward system, with reciprocal projections with the NAc, cortex, habenula and midbrain structures, all of which show altered activation during symptoms of bipolar disorder and in response to drug-associated cues (52-54). Non-overlapping populations of VP efferents (ie. projections to the STN and VTA) are activated in response to drug-associated cues and activity contributes to reinstatement of drug seeking (55, 56). Mahler and colleagues proposed that glutamatergic efferents from the VP to VTA did not modulate VTA DA neuron activity in slice and did not contribute to drug reinstatement. Our results support this interpretation. Our slice results showed mixed EPSCs and IPSCs onto VTA DA neurons from glutamatergic VP efferents, while in vivo recordings, in which network connectivity is preserved, revealed a predominant inhibitory effect of glutamatergic VP neuron activation on VTA DA neuron firing rate. Earlier work demonstrated that the RTMg is activated by aversive stimuli and its activity inhibits VTA DA neurons (57), while activation of LHb projections to the VTA and RMTg is sufficient to induce behavioral aversion (58). Our work extends these findings by identifying and characterizing a discrete population of glutamatergic VP neurons, which modulate activity of the VTA directly and indirectly through polysynaptic effects on LHb and RMTg circuitry. While our study did not determine whether the glutamatergic VP neurons projecting to the LHb, VTA and RMTg are distinct populations, our in vivo results suggest that effects of glutamatergic VP neuron activation on activity of the interconnected habenula and tegmental circuitry, rather than activity of one specific efferent population, mediates behavioral avoidance and constraint of reward seeking.
The ability to up-regulate activity of glutamatergic VP neurons in response to cues triggering inappropriate reward seeking could have potential to inhibit maladaptive reward seeking in psychiatric disorders.
For example, pallidal structures have been shown to be architecturally safe targets for deep brain stimulation in humans and in animal models (59, 60), and advances in region-and cell-type specific drug delivery may soon provide strategies to target VP subpopulations pharmacologically (61-63). Future work will be needed to leverage the unique electrophysiological and genetic properties of glutamatergic VP neurons as a potential treatment strategy for disorders of maladaptive reward seeking. 
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Figure 7. Genetically-encoded, caspase-mediated ablation of glutamatergic VP neurons increases responding for sucrose and impairs sucrose taste aversion learning. (A) Experimental schematic. Mice were trained on an operant task to lever press for a sucrose pellet at fixed ratio (FR) 1 schedule. When performance stabilized on FR1 responding, five sessions each of FR 2, and 3 schedules were completed before baseline operant testing (consisting of FR5 and progressive ratio test sessions). VGluT2-Cre mice or cre-negative controls were then injected bilaterally with cre-dependent viral caspase and testing was resumed. Representative pictomicrographs showing floxed mCherry expression in the VP of unlesioned (left) and taCasp-lesioned (right) mice. (B) There was no effect of geneotype on the initial acquisition of the fixed ratio (FR) responding task (F geneotype = 0.196, p = 0.662; Figure 7B) ; lever presses increased as a function to FR schedule (F session = 314.117, p < 0.001), and there was a significant difference between active and inactive lever presses (F lever = 281.999, p < 0.001). (C) There was no effect of lesion on number of FR5 lever presses (Cre-= pre: 197.83 ± 9. and inactive lever, and a sucrose pellet dispenser (Coulbourn Instruments). During a 60 min session, mice were allowed to lever press for sucrose pellets (Test Diet), an active lever press resulted in a pellet being dispensed. Each press of the active or inactive lever was followed by a 20 sec time-out where further lever presses had no consequence. Following stable lever press responding (less than 20% variation over 5 consecutive test days), mice were moved to an FR2 schedule for 5 days and FR3 schedule for a final five days of training. Following this acquisition, mice were tested for 2 days on an FR5 task, followed by a progressive ratio (PR) session (according to the schedule: 1, 1, 2, 4, 6, 9, 12, 15, 20, 25, 32, 40, 50, 62, 77, 95, 118, 145, 178, 219, 268, 328). This sequence was repeated three times to achieve baseline measurements.
Mice were then injected with AAV5-flex-taCasp-TEV to the VP and allowed three days of recovery following surgery. Testing continued identical to baseline sessions for a total of 10 days. For each significantly modulated, isolated unit, the normalized change in firing rate is plotted against the latency from light onset in the VP to the bin with the maximum change in firing rate from baseline (Left). For each significantly modulated, isolated unit, the absolute firing rate during baseline (off) and during light on-set is plotted (on).
There was no significant difference in the latency to peak change in firing rate or in variance to peak firing rate between brain areas (F2 = 2.701, p = 0.075, RMTg latency to peak: 0.28, var: 0.082 sec, LHb latency to peak: 0.43, var: 0.107 sec, VTA latency to peak: 0.50, var: 0.097 sec), nor was there a significant relationship between latency to peak change and magnitude of peak change in firing rate (RMTg 
